Align succinate-semialdehyde dehydrogenase (NADP+) (EC 1.2.1.79) (characterized)
to candidate WP_009543699.1 CCE_RS19935 NAD-dependent succinate-semialdehyde dehydrogenase
Query= BRENDA::B1XMM6 (454 letters) >NCBI__GCF_000017845.1:WP_009543699.1 Length = 455 Score = 588 bits (1517), Expect = e-173 Identities = 295/455 (64%), Positives = 352/455 (77%), Gaps = 1/455 (0%) Query: 1 MAIATINPTTGEICQRFKALTPAEIDAKLAKAQEAFQAYRRTSFSQRRQWLENAAAILER 60 M IAT+NP TGE + F+ +T EI+ KLA A+ F+ YR+ S QR QWL+ AA ILER Sbjct: 1 MGIATVNPATGETVKIFEPITVDEIEVKLALAETTFRQYRKISLEQRSQWLKAAADILER 60 Query: 61 DTSKFAEIMTTEMGKTHQSAIAEAEKSALVCRYYAEHGEQFLANEYTETQATESYVCYQP 120 D K EIMT EMGK + AIAEA+K ALVCRYYA++ +FL + +T A+ S++ YQP Sbjct: 61 DQQKLGEIMTLEMGKPIKGAIAEAKKCALVCRYYADNAAEFLKDVEAQTDASRSFIRYQP 120 Query: 121 LGILLAVMPWNFPFWQVFRFAAPALMAGNVAVLKHASNVPQCALAVEAILEAAGFPEGVF 180 LG++LAVMPWNFP WQVFRFAAPALMAGNV +LKHASNVPQCALAVEAIL AGFP G F Sbjct: 121 LGVILAVMPWNFPLWQVFRFAAPALMAGNVGILKHASNVPQCALAVEAILAEAGFPAGCF 180 Query: 181 QTLLIGASQVEQVIKDPRVKAATLTGSEPAGASLASLAGQEIKPTLLELGGSDPFVVFPS 240 QT LIGAS+VE +I DPRVKAATLTGSEPAGASLAS AG++IK T+LELGGSDPF+V S Sbjct: 181 QTFLIGASEVESIINDPRVKAATLTGSEPAGASLASAAGKQIKKTVLELGGSDPFIVLES 240 Query: 241 ADLDEAVEVGTVARTMNNGQSCIAAKRFILHEAIAAEFLEKLHLKFASLKIGDPMAPETD 300 AD++ A AR +NNGQSCIAAKRFIL E+IA EF L KF +LK+GDPM +TD Sbjct: 241 ADIEAAATTAVTARMLNNGQSCIAAKRFILAESIADEFQALLLEKFKALKVGDPMEEDTD 300 Query: 301 IGPLATEGILQDISRQVDQAVAAGAKILLGGRPL-DRAGYFYPPTILTEIPPGAKILQEE 359 IGPLA +L ++++QV + V G ILLGG + DR GYFYPPTILT+IP + +E Sbjct: 301 IGPLANASMLLELNQQVQETVTKGGTILLGGHIISDRPGYFYPPTILTDIPVDSPGYYDE 360 Query: 360 LFAPVAMVFTVKDLDQAIALANDIPFGLGASAWTNDPAEQQRFIQELDAGAVFINGMVKS 419 F PVA++F VKD+DQAI LAND FGLGASAWTND AEQ R I++++AG VFINGMVKS Sbjct: 361 FFGPVALLFRVKDIDQAIELANDTIFGLGASAWTNDSAEQDRLIEDIEAGCVFINGMVKS 420 Query: 420 DPRLPFGGTKRSGYGRELGLAGIRTFVNAKTVWLK 454 DPRLPFGG KRSGYGREL + G++ F+N KTVW+K Sbjct: 421 DPRLPFGGIKRSGYGRELSIEGMQEFLNVKTVWIK 455 Lambda K H 0.319 0.134 0.389 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 608 Number of extensions: 28 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 454 Length of database: 455 Length adjustment: 33 Effective length of query: 421 Effective length of database: 422 Effective search space: 177662 Effective search space used: 177662 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory